April 13, 2012
Astellas Pharma Inc. unit OSI Pharmaceuticals LLC, Pfizer Inc. and Genentech Inc. on Friday sued Roxane Laboratories Inc. in Delaware federal court over Roxane's bid for approval to market a generic version of the cancer treatment Tarceva.